It's been four years and the California Institute of Regenerative Medicine is barely off the ground. In June, its newest director, Alan Trounson, allotted $23 million in funding for research on human embryonic stem cells as well as iPS adult stem cell lines, according to the Wall Street Journal. Next, Trounson will fund teams to focus on specific diseases and he hopes to take those therapies to clinical trials within five years.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.